This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Little, H. J. Articles by Taylor, S. C. Search for Related Content PubMed Articles by Little, H. J. Articles by Taylor, S. C. Social Bookmarking                         What's this?

Kindling and withdrawal changes at the benzodiazepine receptor

Department of Pharmacology, The Medical School, University Walk, Bristol

David J. Nutt

NIAAA 9000 Rockeville Pike, Bethesda, Maryland 20205, USA

Stuart C. Taylor

University Department of Pharmacology, South Parks Road, Oxford

Drugs acting at benzodiazepine receptors can have two types of pharmacological profile: benzodiazepine agonists are anxiolytic, anticonvulsant and sedative, whilst benzo diazepine inverse agonists cause anxiety and convulsions. In 1982 we showed that a benzo diazepine antagonist, Ro 15-1788, prevented the effects of both types of compound at doses without intrinsic activity in the tests used. We put forward the hypothesis that the benzo diazepine receptor complex could undergo two possible conformational changes, resulting in increases (benzodiazepine agonists) or decreases (benzodiazepine inverse agonists) in the effects of the inhibitory transmitter -aminobutyric acid (GABA). This concept has been widely accepted. We have now studied the effects of inverse agonists after chronic treatment with inverse agonists themselves and with benzodiazepine agonists, in order to see if tolerance develops (as seen with the agonists) or whether an opposite change occurs.

Journal of Psychopharmacology, Vol. 1, No. 1, 35-46 (1987)
DOI: 10.1177/026988118700100108


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R.R. Brett, P. Jedrusik, W. Laverty, and J.A. Pratt Continuous exposure to FG 7142: behavioural sensitisation is not accompanied by changes in benzodiazepine/GABA receptor coupling J Psychopharmacol, January 1, 1995; 9(3): 223 - 227. [Abstract] [PDF]

				M. H. Lader and S. V. Morton A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal J Psychopharmacol, January 1, 1992; 6(3): 357 - 363. [Abstract] [PDF]

				D. J. Nutt, P. Glue, C. Lawson, and S. Wilson Flumazenil Provocation of Panic Attacks: Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder Arch Gen Psychiatry, October 1, 1990; 47(10): 917 - 925. [Abstract] [PDF]

				L.J. Herberg, A.M.J. Montgomery, and I.C. Rose Evidence that background GABAergic tone and possible ligand release may alter the action of the 'neutral' benzodiazepine-receptor antagonist, Ro 15-1788, in hypothalamic self-stimulation J Psychopharmacol, January 1, 1988; 2(1): 5 - 12. [Abstract] [PDF]